Fujifilm Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Fujifilm Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C0502
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Fujifilm Corp (Fujifilm), a subsidiary of Fujifilm Holdings Corporation, is a provider of imaging and information solutions. The company’s product portfolio encompasses color films, optical devices, digital cameras, photofinishing equipment and color paper, chemicals and services for photofinishing, functional materials, graphic systems, recording media, electronic materials and industrial products, and office printers. The company offers its services to individual consumers and business enterprises. Fujifilm conducts its business operations through its subsidiaries across the Americas, Europe, the Middle East and Africa, and Asia-Pacific. The company is headquartered in Tokyo, Japan.

Fujifilm Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Fujifilm Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Fujifilm Corp, Medical Devices Deals, 2012 to YTD 2018 9
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Fujifilm Corp, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Fujifilm and Takeda Pharma Enter into Agreement 12
RegenxBio Enters into Agreement with Fujifilm Diosynth Biotechnologies 13
EdiGene Enters into Research Agreement with Fujifilm 14
CanBas Enters into Research Agreement with Fujifilm 15
FunPep Enters into Research Agreement with Fujifilm 16
China Resources Pharmaceutical Enters into Agreement with Fujifilm 17
Cynata Therapeutics to Enter into Co-Development Agreement with Fujifilm 18
Bioaster Partners with Fujifilm 19
Fujifilm Enters into Co-Marketing Agreement with Shenzhen Main Luck Pharma 20
Yokogawa Electric Enters Into Co-Marketing Agreement With Wako Pure Chemical Industries For CellVoyager CV7000 21
FUJIFILM Forms Joint Venture With Kyowa Hakko Kirin 22
Licensing Agreements 23
Fujifilm RI Pharma Enters into Licensing Agreement with Advanced Accelerator Applications 23
Zhejiang Hisun Pharma Enters into Licensing Agreement with Fujifilm 24
Equity Offering 25
Fujifilm to Invest USD3.4 Million in Cyfuse Biomedical 25
Fujifilm Invests USD0.3 Million in Japan Biomedical 26
Fujifilm Invests USD1.5 Million in Regcell 27
Acquisition 28
Fujifilm Acquires 11.7% Stake in EdiGene 28
Fujifilm Acquires 6% stake in NC Medical Research for USD3.8 Million 29
Fujifilm Diosynth Biotech Acquires 49% Stake in Kalon Biotherapeutics 30
Fujifilm Corp – Key Competitors 31
Fujifilm Corp – Key Employees 32
Fujifilm Corp – Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Joint Venture 36
Recent Developments 37
Strategy And Business Planning 37
Feb 28, 2017: Expanding Fast-Growing Contract Development and Manufacturing Business for Biopharmaceuticals, FUJIFILM Launches the Bio CDMO Division 37
Other Significant Developments 38
Nov 06, 2017: Fujifilm Expands Biopharmaceutical Contract Development and Manufacturing Business, Increasing Monoclonal Antibody Capacity for Process Development and GMP Production at U.S.A. and U.K. Sites 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Fujifilm Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Fujifilm Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Fujifilm Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Fujifilm Corp, Medical Devices Deals, 2012 to YTD 2018 9
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Fujifilm and Takeda Pharma Enter into Agreement 12
RegenxBio Enters into Agreement with Fujifilm Diosynth Biotechnologies 13
EdiGene Enters into Research Agreement with Fujifilm 14
CanBas Enters into Research Agreement with Fujifilm 15
FunPep Enters into Research Agreement with Fujifilm 16
China Resources Pharmaceutical Enters into Agreement with Fujifilm 17
Cynata Therapeutics to Enter into Co-Development Agreement with Fujifilm 18
Bioaster Partners with Fujifilm 19
Fujifilm Enters into Co-Marketing Agreement with Shenzhen Main Luck Pharma 20
Yokogawa Electric Enters Into Co-Marketing Agreement With Wako Pure Chemical Industries For CellVoyager CV7000 21
FUJIFILM Forms Joint Venture With Kyowa Hakko Kirin 22
Fujifilm RI Pharma Enters into Licensing Agreement with Advanced Accelerator Applications 23
Zhejiang Hisun Pharma Enters into Licensing Agreement with Fujifilm 24
Fujifilm to Invest USD3.4 Million in Cyfuse Biomedical 25
Fujifilm Invests USD0.3 Million in Japan Biomedical 26
Fujifilm Invests USD1.5 Million in Regcell 27
Fujifilm Acquires 11.7% Stake in EdiGene 28
Fujifilm Acquires 6% stake in NC Medical Research for USD3.8 Million 29
Fujifilm Diosynth Biotech Acquires 49% Stake in Kalon Biotherapeutics 30
Fujifilm Corp, Key Competitors 31
Fujifilm Corp, Key Employees 32
Fujifilm Corp, Other Locations 33
Fujifilm Corp, Subsidiaries 34
Fujifilm Corp, Joint Venture 36

List of Figures
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Fujifilm Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Fujifilm Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Renova Energia SA (RNEW11)-エネルギー分野:企業M&A・提携分析
    Summary Renova Energia S.A. (Renova Energia) is a renewable power generation company. It develops, implements and operates power generation projects based on renewable energy sources such as wind, small hydropower and solar; and sells electricity. It also undertakes activities related to manufacturi …
  • Fastenal Co:戦略・SWOT・企業財務分析
    Fastenal Co - Strategy, SWOT and Corporate Finance Report Summary Fastenal Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Brady Corporation:企業の戦略・SWOT・財務分析
    Brady Corporation - Strategy, SWOT and Corporate Finance Report Summary Brady Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Prakash Industries Ltd (PRAKASH):企業の財務・戦略的SWOT分析
    Summary Prakash Industries Ltd (PIL) is a power and steel company. The company’s business activities include mining, steel and power, plastic and wind power. Its mining business division offers explores, acquires and develops iron ore and coal properties. PIL’s steel and power business division prov …
  • Syros Pharmaceuticals Inc (SYRS):医療機器:M&Aディール及び事業提携情報
    Summary Syros Pharmaceuticals Inc (Syros) is a biopharmaceutical company that develops medicines for the treatment of cancer, immune-mediated diseases, and other diseases. The company’s pipeline products under clinical trials include SY-1425, an oral, potent and selective RARa agonist that is used t …
  • Dana Inc:企業の戦略・SWOT・財務分析
    Dana Inc - Strategy, SWOT and Corporate Finance Report Summary Dana Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • NuVasive Inc (NUVA):企業の財務・戦略的SWOT分析
    NuVasive Inc (NUVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Odakyu Electric Railway Co., Ltd.:企業の戦略・SWOT・財務情報
    Odakyu Electric Railway Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Odakyu Electric Railway Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • BESIX Group SA:企業の戦略的SWOT分析
    BESIX Group SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Minerals Technologies Inc (MTX):企業の財務・戦略的SWOT分析
    Minerals Technologies Inc (MTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • CK Infrastructure Holdings Ltd (1038):石油・ガス:M&Aディール及び事業提携情報
    Summary CK Infrastructure Holdings Limited (CKI), a subsidiary of CK Hutchison Holdings Limited, is an infrastructure investment company. It holds diversified investment interests across various sectors including energy, rail transportation, water, waste management, and other infrastructure related …
  • Alfa Laval AB (ALFA):企業の財務・戦略的SWOT分析
    Alfa Laval AB (ALFA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • BYD Co Ltd (1211):企業の財務・戦略的SWOT分析
    BYD Co Ltd (1211) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • UCB S.A.:企業のM&A・事業提携・投資動向
    UCB S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's UCB S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Primearth EV Energy Co Ltd:企業の戦略的SWOT分析
    Primearth EV Energy Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Carisma Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Carisma Therapeutics Inc (Carisma Therapeutics), formerly CARMA Therapeutics LLC, is a biotechnology company with focus on the discovery and development of macrophage-based immunotherapeutics for the treatment of cancer. The company exploits its proprietary CAR-macrophage platform to provide …
  • Probiogen AG-製薬・医療分野:企業M&A・提携分析
    Summary Probiogen AG (Probiogen), a subsidiary of Minapharm Pharmaceuticals & Chemical Industries is a contract development and manufacturing organization that offers cell line engineering, process development and GMP manufacturing of biopharmaceuticals. The organization’s services comprise therapeu …
  • FirstGroup plc (FGP):企業の財務・戦略的SWOT分析
    FirstGroup plc (FGP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Premaitha Health Plc (NIPT):企業の財務・戦略的SWOT分析
    Premaitha Health Plc (NIPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • The Chemours Company LLC:企業の戦略・SWOT・財務情報
    The Chemours Company LLC - Strategy, SWOT and Corporate Finance Report Summary The Chemours Company LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆